title: Endotoxin receptor CD14 gene variants and histological features in chronic HCV infection.
abstract: OBJECTIVE
  To analyze the correlation between CD14 rs2569190/C-159T single nucleotide polymorphism (SNP) and disease progression in chronic hepatitis C.
  
  
  METHODS
  Liver biopsy specimens from a total of 137 and 349 patients with chronic hepatitis C were separately evaluated with respect to necroinflammatory activity (grading) and architectural changes (staging). In one group, further histological lesions characteristic for hepatitis C, hepatitis C virus subtypes, and biochemical parameters of liver disease were also investigated. Samples of genomic DNA were genotyped for the respective SNP by 5'-nuclease assays using fluorescent dye-labeled allele-specific probes.
  
  
  RESULTS
  Genotype distribution did not deviate from the Hardy-Weinberg equilibrium. In the first group, patients homozygous for the variant allele T were found to be younger than C allele carriers (39.6 +/- 12.5 vs 45.7 +/- 11.5, P = 0.008). Among the histological lesions studied, portal lymphoid aggregates were more frequently observed among TT homozygotes than among C carriers (21/37 vs 32/100, P = 0.008). The presence of portal lymphoid aggregates was closely correlated with hepatic inflammation (P = 0.003) and with bile duct damage (P < 0.001). The degree of fibrosis, in contrast, was not found to be related to the CD14 gene C-159T polymorphism.
  
  
  CONCLUSIONS
  The data suggest a possible relationship between CD14 C-159T polymorphism and the formation of portal lymphoid aggregates, but not liver fibrosis progression in chronic hepatitis C.
authors.affiliation: Department of Gastroenterology and Endocrinology, University Medical Center, Georg-August-University, Robert-Koch-Strasse 40, D-37075 Goettingen, Germany.
authors.forename: Eva
authors.initials: E
authors.lastname: Askar
authors.forename: Giuliano
authors.initials: G
authors.lastname: Ramadori
authors.forename: Sabine
authors.initials: S
authors.lastname: Mihm
mesh_terms: D000328:Adult; D018450:Disease Progression; D005260:Female; D020022:Genetic Predisposition to Disease; D005838:Genotype; D016174:Hepacivirus / Q000235:genetics; D019698:Hepatitis C, Chronic / Q000235:genetics* / Q000473:pathology* / Q000503:physiopathology; D006801:Humans; D018950:Lipopolysaccharide Receptors / Q000235:genetics*; D008103:Liver Cirrhosis / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D020641:Polymorphism, Single Nucleotide; D011971:Receptors, Immunologic / Q000235:genetics*
chemical_list: D018950:Lipopolysaccharide Receptors; D011971:Receptors, Immunologic; C048071:endotoxin receptor
references.citation: J Immunol. 2001 Nov 15;167(10):5838-44
references.pmid: 11698458
references.citation: Clin Microbiol Rev. 2008 Jan;21(1):13-25
references.pmid: 18202435
references.citation: Am J Gastroenterol. 1999 Apr;94(4):1006-11
references.pmid: 10201474
references.citation: Hepatology. 2007 Aug;46(2):297-306
references.pmid: 17461418
references.citation: Hepatology. 2001 May;33(5):1148-53
references.pmid: 11343243
references.citation: J Clin Pathol. 1996 Jun;49(6):465-9
references.pmid: 8763259
references.citation: Immunity. 2006 Feb;24(2):153-63
references.pmid: 16473828
references.citation: World J Gastroenterol. 2006 Nov 14;12(42):6756-65
references.pmid: 17106922
references.citation: J Endotoxin Res. 2005;11(4):225-9
references.pmid: 16176659
references.citation: Hepatology. 2003 Sep;38(3):543-4
references.pmid: 12939578
references.citation: Clin Exp Allergy. 2008 Dec;38(12):1929-34
references.pmid: 19037967
references.citation: Scand J Gastroenterol. 2008;43(5):584-92
references.pmid: 18415752
references.citation: Lancet Infect Dis. 2005 Sep;5(9):558-67
references.pmid: 16122679
references.citation: World J Gastroenterol. 2005 Oct 14;11(38):6031-7
references.pmid: 16273620
references.citation: Am J Physiol Gastrointest Liver Physiol. 2002 Aug;283(2):G256-65
references.pmid: 12121871
references.citation: Hepatology. 1995 Aug;22(2):389-94
references.pmid: 7635405
references.citation: Lancet. 1997 Mar 22;349(9055):825-32
references.pmid: 9121257
references.citation: Gastroenterology. 2006 May;130(6):1886-900
references.pmid: 16697751
references.citation: Nat Genet. 2003 Feb;33(2):177-82
references.pmid: 12524541
references.citation: Hepatology. 1997 Mar;25(3):735-9
references.pmid: 9049227
references.citation: Eur J Gastroenterol Hepatol. 2006 Sep;18(9):991-7
references.pmid: 16894313
references.citation: J Med Virol. 2009 Jul;81(7):1204-11
references.pmid: 19475618
references.citation: Dig Dis Sci. 1996 Jun;41(6):1256-64
references.pmid: 8654161
references.citation: Hepatology. 2003 May;37(5):1043-55
references.pmid: 12717385
references.citation: Hepatology. 2002 Nov;36(5 Suppl 1):S35-46
references.pmid: 12407575
references.citation: Hepatology. 1999 Jul;30(1):143-50
references.pmid: 10385650
references.citation: Hepatology. 1994 Jun;19(6):1513-20
references.pmid: 8188183
references.citation: Alcohol Clin Exp Res. 2005 Jul;29(7):1206-13
references.pmid: 16046876
references.citation: Springer Semin Immunopathol. 1997;19(1):99-110
references.pmid: 9266634
references.citation: Immunology. 2004 Oct;113(2):153-62
references.pmid: 15379975
references.citation: Hepatology. 2003 Mar;37(3):493-503
references.pmid: 12601343